We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+17.72%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$18.5B
AUM Growth
+$1.14B
(+6.5%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-7.2%
Top 10 Holdings %
Top 10 Hldgs %
39.28%
Holding
503
New
42
Increased
140
Reduced
229
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$91.1M |
| 2 |
Advanced Micro Devices
AMD
|
+$86.6M |
| 3 |
Broadcom
AVGO
|
+$78.2M |
| 4 |
Vertiv
VRT
|
+$76.7M |
| 5 |
Burlington
BURL
|
+$42.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$142M |
| 2 |
Trip.com Group
TCOM
|
+$101M |
| 3 |
Tesla
TSLA
|
+$87.5M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$83.1M |
| 5 |
Trade Desk
TTD
|
+$80.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.38% |
| 2 | Healthcare | 19.58% |
| 3 | Consumer Discretionary | 11.08% |
| 4 | Industrials | 10.46% |
| 5 | Communication Services | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
IDEAYA Biosciences
IDYA
$3.43B
| $718K | ﹤0.01% |
20,186
+6,716
| +50% | +$200K |
|
377
Nike
NKE
$64.1B
| $693K | ﹤0.01% |
6,379
-17,156
| -73% | -$1.84M |
|
378
Accenture
ACN
$106B
| $685K | ﹤0.01% |
1,953
| – | – |
|
379
SentinelOne
S
$6.35B
| $675K | ﹤0.01% |
24,607
-144,586
| -85% | -$2.8M |
|
380
Agilent Technologies
A
$39.6B
| $643K | ﹤0.01% |
4,624
| – | – |
|
381
New Oriental
EDU
$9.32B
| $616K | ﹤0.01% |
8,400
-4,800
| -36% | -$333K |
|
382
PTC
PTC
$15.3B
| $615K | ﹤0.01% |
3,517
-209
| -6% | -$32.1K |
|
383
Deere & Co
DE
$165B
| $613K | ﹤0.01% |
1,533
-40,372
| -96% | -$15.2M |
|
384
Pacific Biosciences
PACB
$435M
| $609K | ﹤0.01% |
+62,105
| New | +$508K |
|
385
Ball Corp
BALL
$17.5B
| $570K | ﹤0.01% |
9,903
| – | – |
|
386
Crinetics Pharmaceuticals
CRNX
$8.88B
| $557K | ﹤0.01% |
+15,667
| New | +$480K |
|
387
Olema Pharmaceuticals
OLMA
$977M
| $555K | ﹤0.01% |
+39,584
| New | +$532K |
|
388
Rhythm Pharmaceuticals
RYTM
$7.31B
| $542K | ﹤0.01% |
+11,795
| New | +$372K |
|
389
Affirm
AFRM
$23.5B
| $531K | ﹤0.01% |
+10,812
| New | +$313K |
|
390
Super Micro Computer
SMCI
$16.6B
| $520K | ﹤0.01% |
18,300
-1,870
| -9% | -$51.8K |
|
391
Aptiv
APTV
$12.3B
| $510K | ﹤0.01% |
5,682
| – | – |
|
392
Xylem
XYL
$28.5B
| $506K | ﹤0.01% |
4,421
| – | – |
|
393
Tetra Tech
TTEK
$8.77B
| $502K | ﹤0.01% |
15,050
-865
| -5% | -$27.6K |
|
394
Xponential Fitness
XPOF
$286M
| $494K | ﹤0.01% |
38,351
-328,614
| -90% | -$4.45M |
|
395
First Solar
FSLR
$21.4B
| $492K | ﹤0.01% |
2,856
-20,873
| -88% | -$3.19M |
|
396
Synopsys
SNPS
$71.6B
| $475K | ﹤0.01% |
923
-227
| -20% | -$116K |
|
397
Cboe Global Markets
CBOE
$32.2B
| $475K | ﹤0.01% |
+2,660
| New | +$456K |
|
398
Digital Realty Trust
DLR
$69.6B
| $471K | ﹤0.01% |
3,499
+2,227
| +175% | +$288K |
|
|
AMAM
399
DELISTED
Ambrx Biopharma Inc
AMAM
| $468K | ﹤0.01% |
+32,886
| New | +$374K |
|
400
lululemon athletica
LULU
$13.5B
| $462K | ﹤0.01% |
904
-190
| -17% | -$82.1K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q4 2023 Portfolio in Review
As of Q4 2023, Fred Alger Management held 503 positions worth $18.5B, up 6.5% from $17.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Fred Alger Management withdrew a net $1.33B in Q4 2023, closing 60 positions and reducing 229 holdings. Its most notable exit was Albemarle, an estimated $77.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in Micron Technology worth $35.6M.
- Fred Alger Management's largest Q4 2023 buy was Micron Technology: 417,196 shares worth $35.6M.
- Fred Alger Management added most to Amgen in Q4 2023, an estimated $91.1M increase.
- Fred Alger Management's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $142M.
- Fred Alger Management fully exited Albemarle in Q4 2023, selling an estimated $77.2M.
- Fred Alger Management's ten largest holdings make up 39% of its $18.5B portfolio in Q4 2023.
- Fred Alger Management opened 42 new positions and closed 60 in Q4 2023.
- Fred Alger Management's portfolio value rose 6.5% quarter-over-quarter to $18.5B.
Based on Fred Alger Management's 13F filing for Q4 2023, filed 14 Feb 2024.